Articles from Envision Pharma Group
FAIRFIELD, CT / ACCESS Newswire / June 25, 2026 / Envision Pharma Group (Envision) has appointed Jennifer (Jenn) Lospinoso as President of Riparian, its business unit focused on pricing, access, and value optimization for pharmaceutical and biotech companies.
By Envision Pharma Group · Via ACCESS Newswire · June 25, 2026

PHILADELPHIA, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Envision Pharma Group (Envision) has appointed Pauline Bernard to the position of Regional Head, Commercial Strategy, Japan Asia-Pacific (JAPAC).
By Envision Pharma Group · Via GlobeNewswire · February 21, 2023

Pivotal acquisition in Envision Pharma Group's tech-enabled offerings provides clients with access to advanced AI to accelerate decision-making that optimizes their products' path to market and ultimately supports the delivery of enhanced patient outcomes.
By Envision Pharma Group · Via GlobeNewswire · February 7, 2023

PHILADELPHIA, Jan. 31, 2023 (GLOBE NEWSWIRE) -- Envision Pharma Group (Envision) today announced the appointment of two senior executives while further expanding its global focus on M&A, technology-enabled solutions, and strategic consulting for the life sciences industry.
By Envision Pharma Group · Via GlobeNewswire · January 31, 2023